ArticleThe Lancet. Public health2019
Patterns in the relationship between life expectancy and gross domestic product in Russia in 2005-15: a cross-sectional analysis.
Article in The Lancet. Public health, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
23 citing papers in PubMed.
- Restoring life expectancy in low-income countries: the combined impact of COVID-19, health expenditure, GDP, and child mortality.BMC public health · 2025Article
- Health Outcomes in EU Cross-Border Regions: A Scoping Review.Public health reviews · 2025Review
- Social and Economic Determinants of Life Expectancy at Birth in Eastern Europe.Healthcare (Basel, Switzerland) · 2024Article
- Unmet need for healthcare in the Russian Federation: subnational retrospective modelling analysis (2014-2018).BMJ public health · 2024Article
- Impact of education and income inequalities on life expectancy: insights from the new EU members.Frontiers in public health · 2024Article
- Article
- Population health differences in cross-border regions within the European Union and Schengen area: a protocol for a scoping review.BMJ open · 2023Article
- Preventable mortality in the Russian Federation: a retrospective, regional level study.The Lancet regional health. Europe · 2023Article
- Information and communication technology development and health gap nexus in Africa.Frontiers in public health · 2023Article
- Association Between Life Expectancy at Age 60 Years Before the COVID-19 Pandemic and Excess Mortality During the Pandemic in Aging Countries.JAMA network open · 2022Article
- Obesity Prevalence and Associated Socio-Demographic Characteristics and Health Behaviors in Russia and Norway.International journal of environmental research and public health · 2022Article
- Socioeconomic inequalities in physiological risk biomarkers and the role of lifestyles among Russians aged 35-69 years.International journal for equity in health · 2022Article
- GDP, wellbeing, and health: thoughts on the 2017 round of the International Comparison Program.The Review of income and wealth · 2022Article
- Health disparities in Russia at the regional and global scales.International journal for equity in health · 2021Article
- Socio-demographic, behavioural and psycho-social factors associated with depression in two Russian cities.Journal of affective disorders · 2021Article
- The association between various indicators of hospital capacity, age category, and the number of screening tests performed with case fatality rate and recovery rate during the COVID-19 disease pandemic.Journal of preventive medicine and hygiene · 2021Article
- Alcohol control policies in Former Soviet Union countries: A narrative review of three decades of policy changes and their apparent effects.Drug and alcohol review · 2021Review
- Longitudinal trajectories of blood lipid levels in an ageing population sample of Russian Western-Siberian urban population.PloS one · 2021Article
- Quantifying the contribution of established risk factors to cardiovascular mortality differences between Russia and Norway.Scientific reports · 2020Article
- Article
Corrections and comments
- Commented on by
Authors and funding
4 authors.
Funding
Abstract
backgroundSince 2005, Russia has made substantial progress, experiencing an almost doubling of per-capita gross domestic product by purchasing power parity (GDP [PPP]) to US$24 800 and witnessing a 6-year increase in life expectancy, reaching 71·4 years by 2015. Even greater gains in GDP (PPP) were seen for Moscow, the Russian capital, reaching $43 000 in 2015 and with a life expectancy of 75·5 years. We aimed to investigate whether mortality levels now seen in Russia are consistent with what would be expected given this new level of per-capita wealth.
methodsWe used per-capita GDP (PPP) and life expectancy from 61 countries in 2014-15, plus those of Russia as a whole and its capital Moscow, to construct a Preston curve expressing the relationship between mortality and national wealth and to examine the positions of Russia and other populations relative to this curve. We adjusted life expectancy values for Moscow for underestimation of mortality at older ages. For comparison, we constructed another Preston curve based on the same set of countries for the year 2005. We used the stepwise replacement algorithm to decompose mortality differences between Russia or Moscow and comparator countries with similar incomes into age and cause-of-death components.
findingsLife expectancy in 2015 for both Russia and Moscow lay below the Preston-curve-based expectations by 6·5 years and 4·9 years, respectively. In 2015, Russia had a lower per-capita income than 36 of the comparator countries but lower life expectancy than 60 comparator countries. However, the gaps between the observed and the Preston-expected life expectancy values for Russia have diminished by about 25% since 2005, when the life expectancy gap was 8·9 years for Russia and 6·6 years for Moscow. When compared with countries with similar level of income, the largest part of the life expectancy deficit was produced by working-age mortality from external causes for Russia and cardiovascular disease at older ages for Moscow.
interpretationGiven the economic wealth of Russia, its life expectancy could be substantially higher. Sustaining the progress seen over the past decade depends on the ability of the Russian Government and society to devote adequate resources to people's health.
fundingThis work was partly funded through the International Project on Cardiovascular Disease in Russia supported by a Wellcome Trust Strategic Award (100217) and was supported by the Russian Academic Excellence Project 5-100.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.